RxDoctor Payments Data

Andrea Tonasut Millet

Nurse Practitioner · Ridgecrest, CANPI 1285905489

Payments from drug & device makers

$20,194in general payments, 2019–2025

Across 966 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Spinal Simplicity, LLC$2K
  • Forte Bio-pharma LLC$2K
  • Pfizer$2K
  • Collegium Pharmaceutical, Inc.$1K
  • Medtronic$947
  • plus $9K from 41 others

What the payments were for

  • Travel & lodging$1,1536%
  • Food & beverage$17,31586%
  • Education$1,7269%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,194 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen893$465,108
RelistorMethylnaltrexone Bromide72$179,873
Nurtec OdtRimegepant Sulfate156$173,654
OxycontinOxycodone Hcl140$150,263
LinzessLinaclotide168$92,207
Xtampza ErOxycodone Myristate115$89,417
UbrelvyUbrogepant81$81,627
Levorphanol Tartrate31$58,996
QuliptaAtogepant52$57,732
Nucynta ErTapentadol Hcl42$52,798
ZtlidoLidocaine75$47,801
MovantikNaloxegol Oxalate111$44,226
Diclofenac Sodium275$44,140
Aimovig AutoinjectorErenumab-Aooe48$34,571
Fentanyl260$25,906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Ubrelvy, Qulipta$2,760$231,566301 claims
PfizerNurtec Odt, Lyrica$1,977$186,613172 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$225$179,87372 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Nucynta, Belbuca$1,212$178,315201 claims
Virtus Pharmaceuticals LLCLevorphanol Tartrate$216$58,99631 claims
Scilex Pharmaceuticals Inc.Ztlido$611$47,80175 claims
Redhill Biopharma Inc.Movantik$207$44,226111 claims
MerckBelsomra$95$21,81851 claims
Arbor Pharmaceuticals, Inc.Horizant$115$10,85411 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$309$9,32919 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Ridgecrest

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →